Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Purnanta Investment Advisors
Equibles does not estimate personal net worth.
Preetam Kamaji is recorded as Analyst at Purnanta Investment Advisors. Preetam Kamaji has spoken on 2 earnings calls across 2 companies, most recently for Caplin Point Laboratories Limited on November 12, 2026. Those appearances were for Caplin Point Laboratories Limited and BLS International Services Limited. The companies whose calls Preetam Kamaji spoke on are classified in the Healthcare and Industrials sectors.
“So, my question is around U.S. specifically. So, basically, earlier it was targeted that the U.S. revenue would be growing by 25 to 30% in FI27, but as it was instructed now that we are planning for upgradation of some line and there would be slowdown in second half of the FI27.”
“So, my first question is related to net revenue per application. So, now as most of the transition is complete, what growth is company expecting in net revenue per application going ahead?”
Purnanta Investment Advisors
Analyst
Transcript header (unverified)
Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
BLS International Services Limited
Specialty Business Services · Industrials
Earnings Call for the Quarter Ended September 30, 2026
Caplin Point Laboratories Limited
Earnings Call for the Quarter Ended September 30, 2026
BLS International Services Limited